Work

AMCP Market Insights: Payer best practices for timely diagnosis and optimal management of idiopathic hypersomnia

Year: 2025

Type: article

Abstract: Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness. There are challenges to timely, accurate diagnosis of IH and, therefore, to optimal management. To better understand these challenges and identify opportunities, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2024. Key insights from the discussion related to addressing diagnostic challenges in IH, making coverage decisions for medications used in IH, and implementing coverage criteria for medications used in IH. Suggested payer best practices in IH also emerged from the discussion.

Source: Journal of Managed Care & Specialty Pharmacy

DOI: 10.18553/jmcp.2025.31.9-a.s1

Authors: Bridget Flavin, Denise Wolff, Zachary Contreras, Ryan Haumschild, Diana Kimmel, Michael Kobernick, Farzana Rahman

Institutions: Emory Healthcare, Winship Cancer Institute, Hypersomnia Foundation, Blue Cross Blue Shield of Michigan Foundation

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4413842650

FWCI:

Cites: 21

Cited by:

Related to: 10